CBO: Pharmaceutical R&D and the Evolving Market for Drugs
Pharmaceutical R&D and the Evolving Market for Drugs – October 26, 2009 “Investment in research and development (R&D) over the past several decades has produced a wealth of valuable new drug therapies that have made it possible to treat major illnesses that were not treated previously or were not treated as effectively. As the scope …